New Ultra-Low Temperature Freezer Offers Outstanding Sustainability and Sample Protection
A new ultra-low temperature freezer is designed to offer laboratories and biorepositories a greener solution: less power consumption, less noise and higher efficiency without compromising the integrity of samples.
The Thermo Scientific TSX ultra-low temperature freezer features natural refrigerants for lower environmental impact and higher cooling efficiency. Due to its intuitive design, the TSX freezer uses up to 50% less energy than conventional refrigerant ultra-low freezers and delivers temperature uniformity that continuously adapts to a laboratory’s environment.
“Energy efficiency is a feature most lab and biobank managers and sustainability officers look for when making purchasing decisions, but energy savings can come at the expense of sample integrity,” said Chris Champlin, vice president and general manager, Controlled Temperature Technologies at Thermo Fisher Scientific. “The new Thermo Scientific TSX ultra-low temperature freezer delivers unparalleled efficiency, noise reduction, and sample protection. Now, labs and biorepositories can not only reap the benefits of significant energy savings, but also feel confident that their samples are in an environment designed for their protection.”
Conventional ultra-low temperature freezers use single-speed compressors that continually cycle on and off, resulting in poor temperature recovery following door openings. The TSX ultra-low temperature freezer is the only freezer of its kind equipped with the unique V-Drive technology.
When conditions are stable, the V-Drive is designed to operate at a low speed to reduce energy consumption while maintaining a uniform temperature. When dealing with frequent door openings or when samples are added to the freezer, the control system detects the activity and increases the drive speed to bring temperatures quickly back to the set point.
The V-Drive also helps limit sound output to 46 db(A), making the TSX freezer up to 20 times quieter, comparable to a conventional refrigerator. For busy labs and biorepositories, the constant, disruptive noise created by compressors can compromise communications and create a less–than-ideal working environment. What’s more, the freezer utilizes water-blown foam insulation, which eliminates the off-gassing typical of urethane-insulated freezers.
Additional product features include a 600-box sample capacity to maximize storage within a 1.06-m2 footprint, intuitive touch screen interface for access to vital freezer information, and on-board computer and USB port for data storage and exchange.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.